Clinuvel Pharmaceuticals
CUV.AX
#7313
Rank
ยฃ0.28 B
Marketcap
ยฃ5.64
Share price
-0.26%
Change (1 day)
-17.20%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2024: ยฃ45.63 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ45.63 Million. In 2024 the company made a revenue of ยฃ45.63 Million an increase over the revenue in the year 2023 that were of ยฃ40.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2024

Annual revenue

Year Revenue Change
2024ยฃ45.63 M13.83%
2023ยฃ40.09 M14.65%
2022ยฃ34.96 M25.45%
2021ยฃ27.87 M61.08%
2020ยฃ17.3 M2.65%
2019ยฃ16.85 M15.55%
2018ยฃ14.59 M46.83%
2017ยฃ9.93 M176.95%
2016ยฃ3.58 M107.69%
2015ยฃ1.72 M7.83%
2014ยฃ1.6 M45.96%
2013ยฃ1.09 M91.73%
2012ยฃ0.57 M-33.49%
2011ยฃ0.86 M
2010N/A
2009N/A
2008N/A-100%
2007ยฃ0.18 M-57.21%
2006ยฃ0.43 M489.62%
2005ยฃ0.07 M
2004N/A
2002N/A
2001N/A